Medical Oncology clinical trials
Name: REAL PRO
Registry-based Study of Enzalutamide vs Abiraterone assessing cognitive function in ELderly patients with Metastatic Castration-Resistant Prostate Cancer.
Principal Investigator: Dr Malmaruha Arasaratnam
Study Coordinator: Abraham Mathews
Status: Recruiting
Condition: Prostate Cancer
More information about REAL PRO
Name: DASL HiCaP
Darolutamide Augments Standard Therapy for Localised Very High-Risk Cancer of the Prostate (ANZUP1801). A randomized phase 3 double-blind, placebo-controlled trial of adding Darolutamide to androgen deprivation therapy and definitive or salvage radiation in very high risk, clinically localised prostate cancer.
Principal Investigator: Dr Craig Kukard
Study Coordinator: Abraham Mathews
Status: Recruiting
Condition: Prostate Cancer
More information about DASL HiCaP
More information
For more information about medical oncology clinical trials, please contact the Nurse Unit Manager on 02 4320 9890 or see:
Radiation Oncology clinical trials
Name: OPTIMAL
Optimal Prostate Fractional Study
Principal Investigator: Prof Andrew Kneebone
Study Coordinator: Abraham Mathews
Status: Recruiting
Condition: Prostate Cancer
More Information about OPTIMAL